Credit Suisse Downgrades Medical Properties Trust to Neutral, Lowers Price Target to $17
Credit Suisse analyst Omotayo Okusanya downgrades Medical Properties Trust (NYSE:MPW) from Outperform to Neutral and lowers the price target from $23 to $17.